| 000 | 01794 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514164727.0 | ||
| 264 | 0 | _c20050104 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a1359-4184 | ||
| 024 | 7 |
_a10.1038/sj.mp.4001474 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAvale, M E | |
| 245 | 0 | 0 |
_aThe dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. _h[electronic resource] |
| 260 |
_bMolecular psychiatry _cJul 2004 |
||
| 300 |
_a718-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAmphetamine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Outbred Strains |
| 650 | 0 | 4 |
_aAttention Deficit Disorder with Hyperactivity _xdrug therapy |
| 650 | 0 | 4 |
_aBehavior, Animal _xphysiology |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xpharmacology |
| 650 | 0 | 4 |
_aCorpus Striatum _xcytology |
| 650 | 0 | 4 | _aDenervation |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylphenidate _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMotor Activity _xphysiology |
| 650 | 0 | 4 | _aNeural Pathways |
| 650 | 0 | 4 | _aOxidopamine |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xgenetics |
| 650 | 0 | 4 | _aReceptors, Dopamine D4 |
| 650 | 0 | 4 |
_aSubstantia Nigra _xcytology |
| 650 | 0 | 4 | _aSympatholytics |
| 700 | 1 | _aFalzone, T L | |
| 700 | 1 | _aGelman, D M | |
| 700 | 1 | _aLow, M J | |
| 700 | 1 | _aGrandy, D K | |
| 700 | 1 | _aRubinstein, M | |
| 773 | 0 |
_tMolecular psychiatry _gvol. 9 _gno. 7 _gp. 718-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.mp.4001474 _zAvailable from publisher's website |
| 999 |
_c14429904 _d14429904 |
||